Patents Assigned to GlaxoSmithKline Australia Pty. Ltd.
  • Methods of altering poppy characteristics
    Patent number: 8557737
    Abstract: The present invention relates to the use of sulfonylurea compounds to alter physical and/or growth characteristics of poppy plants.
    Type: Grant
    Filed: August 17, 2006
    Date of Patent: October 15, 2013
    Assignee: GlaxoSmithKline Australia, Pty, Ltd
    Inventor: Paul Cotterill
  • Method of altering the alkaloid composition in poppy plants
    Patent number: 8377851
    Abstract: The method of altering the alkaloid composition of a poppy plant comprising the step of applying an effective amount of acylcyclohexanedione compound or agriculturally acceptable salt thereof to said poppy plant or locus thereof. Further, the present invention also provides the method of altering the alkaloid composition of a poppy plant comprising the step of applying an effective amount of methyl jasmonate or agriculturally acceptable salt thereof to said poppy plant or locus thereof.
    Type: Grant
    Filed: May 6, 2005
    Date of Patent: February 19, 2013
    Assignee: GlaxoSmithKline Australia Pty. Ltd.
    Inventor: Paul Cotterill
  • Process for the synthesis of morphinane compounds and intermediates thereof
    Patent number: 8106201
    Abstract: This invention relates to intermediates useful in the preparation of opiate alkaloids, particularly morphinane compounds. The invention also relates to processes for preparing such intermediates and to processes which utilise such intermediates in the synthesis of morphinane compounds.
    Type: Grant
    Filed: January 3, 2011
    Date of Patent: January 31, 2012
    Assignees: Johnson Matthey Public Limited Company, GlaxoSmithKline Australia Pty. Ltd.
    Inventors: Craig Smith, Stuart Purcell, Lucy Waddell, Nicholas Hayes, Jarrod Ritchie, Scott Brian Halliday, Melville Mitchell, George Scott Wilson
  • PROCESS FOR THE SYNTHESIS OF MORPHINANE COMPOUNDS AND INTERMEDIATES THEREOF
    Publication number: 20110098474
    Abstract: This invention relates to intermediates useful in the preparation of opiate alkaloids, particularly morphinane compounds. The invention also relates to processes for preparing such intermediates and to processes which utilise such intermediates in the synthesis of morphinane compounds.
    Type: Application
    Filed: January 3, 2011
    Publication date: April 28, 2011
    Applicants: JOHNSON MATTHEY PUBLIC LIMITED COMPANY, GLAXOSMITHKLINE AUSTRALIA PTY. LTD.
    Inventors: Craig Smith, Stuart Purcell, Lucy Waddell, Nicholas Hayes, Jarrod Ritchie, Scott Brian Halliday, Melville Mitchell, George Scott Wilson
  • Process for the synthesis of morphinane compounds and intermediates thereof
    Patent number: 7875718
    Abstract: This invention relates to intermediates useful in the preparation of opiate alkaloids, particularly morphinane compounds. The invention also relates to processes for preparing such intermediates and to processes which utilise such intermediates in the synthesis of morphinane compounds.
    Type: Grant
    Filed: March 19, 2007
    Date of Patent: January 25, 2011
    Assignees: Johnson Matthey Public Limited Company, GlaxoSmithKline Australia Pty. Ltd.
    Inventors: Craig Smith, Stuart Purcell, Lucy Waddell, Nicholas Hayes, Jarrod Ritchie, Scott Brian Halliday, Melville Mitchell, George Scott Wilson
  • Method of Altering the Alkaloid Composition in Poppy Plants
    Publication number: 20090075822
    Abstract: The method of altering the alkaloid composition of a poppy plant comprising the step of applying an effective amount of acylcyclohexanedione compound or agriculturally acceptable salt thereof to said poppy plant or locus thereof. Further, the present invention also provides the method of altering the alkaloid composition of a poppy plant comprising the step of applying an effective amount of methyl jasmonate or agriculturally acceptable salt thereof to said poppy plant or locus thereof.
    Type: Application
    Filed: May 6, 2005
    Publication date: March 19, 2009
    Applicant: GLAXOSMITHKLINE AUSTRALIA PTY LTD
    Inventor: Paul Cotterill